A mesenchymalis őssejteket (MSC-ket) már számos szövettípusból sikeresen izolálták. Ezek a sejtek terápiás felhasználás szempontjából különösen ígéretesnek tűnnek a felnőtt szöveti őssejtek közül, mivel könnyen izolálhatók, és viszonylag egyszerű a fenntartásuk és szaporításuk in vitro, valamint képesek számos sejttípussá, többek között csont-, porc-, ín-, izom- és zsírsejtekké alakulni. A szervezetben ezek a sejtek biztosítják azokat a növekedési faktorokat és cytokineket, amelyek a vérképző sejtek osztódását és differenciálódását szabályozzák. In vivo képesek lehetnek sérült szövetek regenerálására a vesében, szívben, májban, hasnyálmirigyben és az emésztőrendszerben. Emellett az MSC-k immunmoduláló és gyulladáscsökkentő hatással is rendelkeznek, és allogén szervezetben is csak minimális immunválaszt váltanak ki. Bár a folyamat háttere még nem teljesen ismert, az e sejtek immunszuppresszív hatásán alapuló módszerek már a klinikai kipróbálás fázisában vannak, és lehetséges, hogy a jövőben az MSC-k segítségével allograft-kilökődés, graft versus host betegség, rheumatoid arthritis, autoimmun eredetű ízületi gyulladás és más olyan betegségek lesznek kezelhetők, amelyek esetében immunszuppresszió és szöveti regeneráció is szükséges. A jelen összefoglaló célja a mesenchymalis őssejtekről szóló irodalom áttekintése, különös tekintettel azok immunmoduláló tulajdonságaira és jövőbeli lehetséges klinikai felhasználására.
Friedenstein, A. J., Chailakhyan, R. K., Gerasimov, U. V.: Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet., 1987, 20 , 263–272.
Gerasimov U. V. , 'Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers ' (1987 ) 20 Cell Tissue Kinet. : 263 -272.
Pittenger, M. F., Mackay, A. M., Beck, S. C. és mtsai: Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284 , 143–147.
Beck S. C. , 'Multilineage potential of adult human mesenchymal stem cells ' (1999 ) 284 Science : 143 -147.
Azizi, S. A., Stokes, D., Augelli, B. J. és mtsai: Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA, 1998, 95 , 3908–3913.
Augelli B. J. , 'Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts ' (1998 ) 95 Proc. Natl. Acad. Sci. USA : 3908 -3913.
Sanchez-Ramos, J. R.: Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosci. Res., 2002, 69 , 880–893.
Sanchez-Ramos J. R. , 'Neural cells derived from adult bone marrow and umbilical cord blood ' (2002 ) 69 J. Neurosci. Res. : 880 -893.
Woodbury, D., Schwarz, E. J., Prockop, D. J. és mtsa: Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res., 2000, 61 , 364–370.
Prockop D. J. , 'Adult rat and human bone marrow stromal cells differentiate into neurons ' (2000 ) 61 J. Neurosci. Res. : 364 -370.
Oh, S. H., Muzzonigro, T. M., Bae, S. H. és mtsai: Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab. Invest., 2004, 84 , 607–617.
Bae S. H. , 'Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes ' (2004 ) 84 Lab. Invest. : 607 -617.
Petersen, B. E., Bowen, W. C., Patrene, K. D. és mtsai: Bone marrow as a potential source of hepatic oval cells. Science, 1999, 284 , 1168–1170.
Patrene K. D. , 'Bone marrow as a potential source of hepatic oval cells ' (1999 ) 284 Science : 1168 -1170.
Tang, D. Q., Cao, L. Z., Burkhardt, B. R. és mtsai: In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes, 2004, 53 , 1721–1732.
Burkhardt B. R. , 'In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow ' (2004 ) 53 Diabetes : 1721 -1732.
da Silva Meirelles, L., Chagastelles, P. C., Nardi, N. B.: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell. Sci., 2006, 119 , 2204–2213.
Nardi N. B. , 'Mesenchymal stem cells reside in virtually all post-natal organs and tissues ' (2006 ) 119 J. Cell. Sci. : 2204 -2213.
Pierdomenico, L., Bonsi, L., Calvitti, M. és mtsai: Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation, 2005, 80 , 836–842.
Calvitti M. , 'Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp ' (2005 ) 80 Transplantation : 836 -842.
Zuk, P. A., Zhu, M., Mizuno, H. és mtsai: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng., 2001, 7 , 211–228.
Mizuno H. , 'Multilineage cells from human adipose tissue: implications for cell-based therapies ' (2001 ) 7 Tissue Eng. : 211 -228.
Erices, A., Conget, P., Minguell, J. J.: Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol., 2000, 109 , 235–242.
Minguell J. J. , 'Mesenchymal progenitor cells in human umbilical cord blood ' (2000 ) 109 Br. J. Haematol. : 235 -242.
Anjos-Afonso, F., Siapati, E. K., Bonnet, D.: In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell. Sci., 2004, 117 , 5655–5664.
Bonnet D. , 'In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions ' (2004 ) 117 J. Cell. Sci. : 5655 -5664.
Gao, J., Dennis, J. E., Muzic, R. F. és mtsai: The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs, 2001, 169 , 12–20.
Muzic R. F. , 'The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion ' (2001 ) 169 Cells Tissues Organs : 12 -20.
Zannettino, A. C., Paton, S., Arthur, A. és mtsai: Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J. Cell. Physiol., 2008, 214 , 413–421.
Arthur A. , 'Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo ' (2008 ) 214 J. Cell. Physiol. : 413 -421.
Chamberlain, G., Fox, J., Ashton, B. és mtsa: Mesenchymal Stem Cells: their Phenotype, Differentiation Capacity, Immunological Features and Potential for Homing. Stem Cells, 2007, 25 , 2739–2749.
Ashton B. , 'Mesenchymal Stem Cells: their Phenotype, Differentiation Capacity, Immunological Features and Potential for Homing ' (2007 ) 25 Stem Cells : 2739 -2749.
Horwitz, E. M., Prockop, D. J., Fitzpatrick, L. A. és mtsai: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med., 1999, 5 , 309–313.
Fitzpatrick L. A. , 'Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta ' (1999 ) 5 Nat. Med. : 309 -313.
Le Blanc, K., Tammik, L., Sundberg, B. és mtsai: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol., 2003, 57 , 11–20.
Sundberg B. , 'Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex ' (2003 ) 57 Scand. J. Immunol. : 11 -20.
Di Nicola, M., Carlo-Stella, C., Magni, M. és mtsai: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99 , 3838–3843.
Magni M. , 'Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli ' (2002 ) 99 Blood : 3838 -3843.
Ryan, J. M., Barry, F., Murphy, J. M. és mtsa: Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol., 2007, 149 , 353–363.
Murphy J. M. , 'Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells ' (2007 ) 149 Clin. Exp. Immunol. : 353 -363.
Ryan, J. M., Barry, F., Murphy, J. M. és mtsa: Mesenchymal stem cells avoid allogeneic rejection. J. Inflamm. (Lond), 2005, 8 , 8.
Murphy J. M. , 'Mesenchymal stem cells avoid allogeneic rejection ' (2005 ) 8 J. Inflamm. (Lond) : 8 -.
Augello, A., Tasso, R., Negrini, S. M. és mtsa: Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol., 2005, 35 , 1482–1490.
Negrini S. M. , 'Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway ' (2005 ) 35 Eur. J. Immunol. : 1482 -1490.
Maccario, R., Podestà, M., Moretta, A. és mtsai: Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005, 90 , 516–525.
Moretta A. , 'Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype ' (2005 ) 90 Haematologica : 516 -525.
Prevosto, C., Zancolli, M., Canevali, P. és mtsai: Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica, 2007, 92 , 881–888.
Canevali P. , 'Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction ' (2007 ) 92 Haematologica : 881 -888.
Rasmusson, I.: Immune modulation by mesenchymal stem cells. Exp. Cell. Res., 2006, 312 , 2169–2179.
Rasmusson I. , 'Immune modulation by mesenchymal stem cells ' (2006 ) 312 Exp. Cell. Res. : 2169 -2179.
Aggarwal, S. és Pittenger, M. F.: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105 , 1815–1822.
Pittenger M. F. , 'Human mesenchymal stem cells modulate allogeneic immune cell responses ' (2005 ) 105 Blood : 1815 -1822.
Ramasamy, R., Fazekasova, H., Lam, E. W. és mtsai: Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 2007, 83 , 71–76.
Lam E. W. , 'Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle ' (2007 ) 83 Transplantation : 71 -76.
Jiang, X. X., Zhang, Y., Liu, B. és mtsai: Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 2005, 105 , 4120–4126.
Liu B. , 'Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells ' (2005 ) 105 Blood : 4120 -4126.
Corcione, A., Benvenuto, F., Ferretti, E. és mtsai: Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107 , 367–372.
Ferretti E. , 'Human mesenchymal stem cells modulate B-cell functions ' (2006 ) 107 Blood : 367 -372.
Rasmusson, I., Le Blanc, K., Sundberg, B. és mtsa: Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol., 2007, 65 , 336–343.
Sundberg B. , 'Mesenchymal stem cells stimulate antibody secretion in human B cells ' (2007 ) 65 Scand. J. Immunol. : 336 -343.
Spaggiari, G. M., Capobianco, A., Becchetti, S. és mtsai: Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 2006, 107 , 1484–1490.
Becchetti S. , 'Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation ' (2006 ) 107 Blood : 1484 -1490.
Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D. és mtsai: Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 2006, 24 , 74–85.
Gritzapis A. D. , 'Interactions between human mesenchymal stem cells and natural killer cells ' (2006 ) 24 Stem Cells : 74 -85.
Bartholomew, A., Sturgeon, C., Siatskas, M. és mtsai: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol., 2002, 30 , 42–48.
Siatskas M. , 'Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo ' (2002 ) 30 Exp. Hematol. : 42 -48.
Le Blanc, K. és Ringden, O.: Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr. Opin. Immunol., 2006, 18 , 586–591.
Ringden O. , 'Mesenchymal stem cells: properties and role in clinical bone marrow transplantation ' (2006 ) 18 Curr. Opin. Immunol. : 586 -591.
Gerdoni, E., Gallo, B., Casazza, S. és mtsai: Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol., 2007, 61 , 219–227.
Casazza S. , 'Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis ' (2007 ) 61 Ann. Neurol. : 219 -227.
Zappia, E., Casazza, S., Pedemonte, E. és mtsai: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 2005, 106 , 1755–1761.
Pedemonte E. , 'Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy ' (2005 ) 106 Blood : 1755 -1761.
Xu, J., Woods, C. R., Mora, A. L. és mtsai: Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell Mol. Physiol., 2007, 293 , L131–141.
Mora A. L. , 'Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice ' (2007 ) 293 Am. J. Physiol. Lung Cell Mol. Physiol. : L131 -141.
Rojas, M., Xu, J., Woods, C. R. és mtsai: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Cell. Mol. Biol., 2005, 33 , 145–152.
Woods C. R. , 'Bone marrow-derived mesenchymal stem cells in repair of the injured lung ' (2005 ) 33 Am. J. Respir. Cell. Mol. Biol. : 145 -152.
Djouad, F., Fritz, V., Apparailly, F. és mtsai: Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum., 2005, 52 , 1595–603.
Apparailly F. , 'Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis ' (2005 ) 52 Arthritis Rheum. : 1595 -603.
Augello, A., Tasso, R., Negrini, S. M. és mtsai: Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum., 2007, 56 , 1175–1186.
Negrini S. M. , 'Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis ' (2007 ) 56 Arthritis Rheum. : 1175 -1186.
Le Blanc, K., Rasmusson, I., Sundberg, B. és mtsai: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 2004, 363 , 1439–1441.
Sundberg B. , 'Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells ' (2004 ) 363 Lancet : 1439 -1441.
Klyushnenkova, E., Mosca, J. D., Zernetkina, V. és mtsai: T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci., 2005, 12 , 47–57.
Zernetkina V. , 'T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression ' (2005 ) 12 J. Biomed. Sci. : 47 -57.
Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B. és mtsai: Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood, 2006, 108 , 2114–2120.
Kruisselbrink A. B. , 'Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting ' (2006 ) 108 Blood : 2114 -2120.
Chan, J. L., Tang, K. C., Patel, A. P. és mtsai: Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood, 2006, 107 , 4817–4824.
Patel A. P. , 'Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma ' (2006 ) 107 Blood : 4817 -4824.
Rubio, D., Garcia-Castro, J., Martín, M. C. és mtsai: Spontaneous human adult stem cell transformation. Cancer Res., 2005, 65 , 3035–3039.
Martín M. C. , 'Spontaneous human adult stem cell transformation ' (2005 ) 65 Cancer Res. : 3035 -3039.
Miura, M., Miura, Y., Padilla-Nash, H. M. és mtsai: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 2006, 24 , 1095–1103.
Padilla-Nash H. M. , 'Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation ' (2006 ) 24 Stem Cells : 1095 -1103.
Djouad, F., Plence, P., Bony, C. és mtsai: Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102 , 3837–3844.
Bony C. , 'Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals ' (2003 ) 102 Blood : 3837 -3844.
Chen, X., McClurg, A., Zhou, G. Q. és mtsai: Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells, 2007, 25 , 364–370.
Zhou G. Q. , 'Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules ' (2007 ) 25 Stem Cells : 364 -370.
Le Blanc, K., Tammik, C., Rosendahl, K. és mtsai: HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol., 2003, 31 , 890–896.
Rosendahl K. , 'HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells ' (2003 ) 31 Exp. Hematol. : 890 -896.
Breitbach, M., Bostani, T., Roell, W. és mtsai: Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 2007, 110 , 1362–1369.
Roell W. , 'Potential risks of bone marrow cell transplantation into infarcted hearts ' (2007 ) 110 Blood : 1362 -1369.